Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting - Edgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, Carlos Vrech, María A Zarate

Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care - The Lancet Neurology

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Improving the Diagnosis of Neuromyelitis Optica Spectrum Disorder - Neurology Advisor

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis

KJR :: Korean Journal of Radiology

Sensors, Free Full-Text

KJR :: Korean Journal of Radiology

EPOS™ - C-14374

Frontiers Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease

Frontiers Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis - Silvia Messina, Romina Mariano, Adriana Roca-Fernandez, Ana Cavey, Maciej Jurynczyk, Maria Isabel Leite, Massimiliano Calabrese, Mark